ProPhase Labs, Inc.
PRPH- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000868278
No open-market purchases or sales by ProPhase Labs, Inc. insiders were filed in the last 90 days; 2 institutions reported holding it in 13F filings for Q2 2026, worth $2 in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding ProPhase Labs, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 45 | 35 | −10 |
| Shares | 2.18M | 1.96M | −215.5K (−9.9%) |
| Value | $15.8M | $8.56M | −$7.23M (−45.8%) |
New holders (5)
Institutions that held ProPhase Labs, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HighTower Advisors, LLC | 173,124 | $756.0K | 0.00% |
| Goldman Sachs Group Inc | 88,163 | $385.3K | 0.00% |
| Boston Private Wealth LLC | 47,665 | $208.3K | 0.00% |
| Qube Research & Technologies Ltd | 25 | $109 | 0.00% |
| Capital Advisors, Ltd. LLC | 90 | $0 | 0.00% |
Sold out (15)
Institutions that held ProPhase Labs, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Avidian Wealth Solutions, LLC | 156,024 | $1.13M |
| Ameriprise Financial Inc | 92,729 | $673.2K |
| Globeflex Capital L P | 56,175 | $407.8K |
| First Trust Advisors LP | 37,333 | $271.0K |
| Ritholtz Wealth Management | 23,390 | $169.8K |
| Occudo Quantitative Strategies LP | 13,117 | $95.2K |
| Precision Wealth Strategies, LLC | 12,392 | $90.0K |
| Squarepoint Ops LLC | 12,076 | $87.7K |
| Marshall Wace, LLP | 11,255 | $81.7K |
| Susquehanna International Group, LLP | 11,014 | $80.0K |
| Jane Street Group, LLC | 10,234 | $74.3K |
| Covestor Ltd | 5,015 | $36.0K |
| IFP Advisors, Inc | 834 | $2.88K |
| Barclays PLC | 148 | $1.07K |
| Spire Wealth Management | 80 | $581 |